Purpose:
The primary purpose of the KidCOVE Study is to test the safety and effectiveness of the study vaccine, called mRNA-1273, that may protect children between the ages of 6 months to < 12 years from getting sick if they come into contact with SARS-CoV-2, which causes COVID-19.
What to Expect:
Participation in the KidCOVE Study lasts approximately 14 months and includes phone calls, telemedicine visits, and up to seven visits to the study site.
The study doctor and medical staff will talk to you and your child about additional medical support that your child will receive if he/she experiences COVID-19 symptoms at any time while in this clinical trial. Insurance is not needed to join this clinical trial, and compensation for your family’s time will be available.
Eligibility Criteria:
Participant must:
Participant must not:
Length / Duration:
Participation in the KidCOVE Study lasts approximately 14 months and includes phone calls, telemedicine visits, and up to seven visits to the study site.
Location:
13229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Who should you contact:
Recruitment Department: (407) 350-3979
We’ll check to see if your child is eligible by asking you some questions.
Tell us a little bit about yourself. We will contact you for additional information to determine your eligibility for current and future studies.
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2022 Kissimmee Clinical Research- All rights reserved
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.